共 50 条
- [41] Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) : 13780 - 13792Down, Kenneth论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England Benevolent AI, 4-8 Maple St, London W1T 5HD, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandAmour, Augustin论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandAnderson, Niall A.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandBarton, Nick论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandCampos, Sebastien论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England Drug Discovery Serv Europe, West Hill Innovat Pk,Hertford Rd, Hoddesdon EN11 9FH, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandCannons, Edward P.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandClissold, Cole论文数: 0 引用数: 0 h-index: 0机构: Charles River Discovery, Saffron Walden CB10 1XL, Essex, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandConvery, Maire A.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandCoward, John J.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandDoyle, Kevin论文数: 0 引用数: 0 h-index: 0机构: Charles River Discovery, Saffron Walden CB10 1XL, Essex, England Cerevance Ltd, 418 Cambridge Sci Pk, Cambridge CB4 0PZ, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandDuempelfeld, Birgit论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Co, Cellzome GmbH, D-69117 Heidelberg, Germany GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandEdwards, Christopher D.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandGoldsmith, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Charles River Discovery, Saffron Walden CB10 1XL, Essex, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandKrause, Jana论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Co, Cellzome GmbH, D-69117 Heidelberg, Germany GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandMallett, David N.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandMcGonagle, Grant A.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandPatel, Vipulkumar K.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandRowedder, James论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandRowland, Paul论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandSharpe, Andrew论文数: 0 引用数: 0 h-index: 0机构: Charles River Discovery, Saffron Walden CB10 1XL, Essex, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandSriskantharajah, Srividya论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandThomas, Daniel A.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England Arctoris, 120E Olymp Ave,Milton Pk, Abingdon OX14 4SA, Oxon, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandThomson, Douglas W.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline Co, Cellzome GmbH, D-69117 Heidelberg, Germany GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandUddin, Sorif论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandHamblin, J. Nicole论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England Charles River Discovery, Saffron Walden CB10 1XL, Essex, England GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, EnglandHessel, Edith M.论文数: 0 引用数: 0 h-index: 0机构: GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England Eligo Biosci, 29 Rue Faubourg St Jacques, F-75014 Paris, France GlaxoSmithKline R&D, Med Res Ctr, Stevenage SG1 2NY, Herts, England
- [42] Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1767 - 1772Ohwada, Jun论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanEbiike, Hirosato论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanKawada, Hatsuo论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanTsukazaki, Masao论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanNakamura, Mitsuaki论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanMiyazaki, Takuya论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanMorikami, Kenji论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanYoshinari, Kiyoshi论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanYoshida, Miyuki论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanKondoh, Osamu论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanKuramoto, Shino论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanOgawa, Kotaro论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanAoki, Yuko论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, JapanShimma, Nobuo论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan Chugai Pharmaceut Co Ltd, Div Res, Kanagawa 2478530, Japan
- [43] Discovery of a novel photoswitchable PI3K inhibitor toward optically-controlled anticancer activity[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 72Zhang, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Druggabil Ev, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaPeng, Shouguo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Druggabil Ev, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaLin, Songwen论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Druggabil Ev, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaJi, Ming论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaDu, Tingting论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaChen, Xiaoguang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R ChinaXu, Heng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, CAMS Key Lab Small Mol Immunooncol Drug Discovery, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Act Subst Discovery & Druggabil Ev, Beijing 100050, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
- [44] Discovery of CT365, a highly potent inhibitor of PI3K and mTOR, for cancer treatment[J]. CANCER RESEARCH, 2015, 75Xi, Ning论文数: 0 引用数: 0 h-index: 0机构: Calitor Sci LLC, Newbury Pk, CA USA Calitor Sci LLC, Newbury Pk, CA USAWu, Yanjun论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USAWang, Tingjin论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USAWang, Heng论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USALi, Zhiyong论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USAMeng, Qingwei论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USALi, Jing论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USAWang, Zhaohe论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USAZhang, Yingjun论文数: 0 引用数: 0 h-index: 0机构: Sunshine Lake Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China Calitor Sci LLC, Newbury Pk, CA USA
- [45] Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms[J]. RSC ADVANCES, 2019, 9 (35) : 20207 - 20215Zhu, Jingyu论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R ChinaKe, Ke论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R ChinaXu, Lei论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Univ Technol, Sch Elect & Informat Engn, Inst Bioinformat & Med Engn, Changzhou 213001, Peoples R China Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R ChinaJin, Jian论文数: 0 引用数: 0 h-index: 0机构: Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Jiangsu, Peoples R China
- [46] Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignancies[J]. FRONTIERS IN PHARMACOLOGY, 2024, 15Jiang, Shuwen论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaLi, Xiangkun论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaXue, Weifang论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaXia, Sumei论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaWang, Jian论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaSai, Yang论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaDai, Guangxiu论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R ChinaSu, Weiguo论文数: 0 引用数: 0 h-index: 0机构: HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China HUTCHMED Ltd, Zhangjiang Hitech Pk, Shanghai, Peoples R China
- [47] A Novel Dual PI3K/mTOR Inhibitor, XIN-10, for the Treatment of Cancer[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)Sun, Xin论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaYang, Yang论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaXia, Lulu论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaWang, Shiyu论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaFu, Yuxing论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaZhu, Yuxuan论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaXu, Shan论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaZhu, Wufu论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R ChinaZhu, Wufu论文数: 0 引用数: 0 h-index: 0机构: Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China Jiangxi Sci & Technol Normal Univ, Sch Pharm, Jiangxi Prov Key Lab Drug Design & Evaluat, 605 Fenglin Rd, Nanchang 330013, Peoples R China
- [48] Discovery of a novel series of potent and selective Phosphatidylinositol-3-Kinase delta (PI3Kδ) inhibitors for the treatment of inflammatory and autoimmune diseases[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253Aguilar, Nuria论文数: 0 引用数: 0 h-index: 0机构: Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainCarles Fernandez, Joan论文数: 0 引用数: 0 h-index: 0机构: Unitat Mixta Almirall PCB, Barcelona, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainHernandez, Begona论文数: 0 引用数: 0 h-index: 0机构: Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainCarrascal, Marta论文数: 0 引用数: 0 h-index: 0机构: Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainNino, Patricia论文数: 0 引用数: 0 h-index: 0机构: Unitat Mixta Almirall PCB, Barcelona, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainLopez, Alba论文数: 0 引用数: 0 h-index: 0机构: Unitat Mixta Almirall PCB, Barcelona, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainVazquez, Laura论文数: 0 引用数: 0 h-index: 0机构: Unitat Mixta Almirall PCB, Barcelona, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainLozoya, Estrella论文数: 0 引用数: 0 h-index: 0机构: Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, SpainMaldonado, Monica论文数: 0 引用数: 0 h-index: 0机构: Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain Almirall, Med Chem & Screening, Sant Feliu de Llobregat, Catalonia, Spain
- [49] Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer[J]. BIOORGANIC CHEMISTRY, 2023, 140Yang, Chengbin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaWang, Menghui论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaGong, Yimin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaDeng, Mingli论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaLing, Yun论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaLi, Qingquan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaWang, Jianxin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R ChinaZhou, Yaming论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China
- [50] INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer[J]. CANCER RESEARCH, 2011, 71Jessen, Katayoun A.论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAKessler, Linda论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAKucharski, Jeff论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAGuo, Xin论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAStaunton, Jocelyn论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAElia, Marikka论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAJanes, Matthew论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USALan, Lucy论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAWang, Shunyou论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAStewart, Josh论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USADarjania, Levan论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USALi, Liansheng论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAChan, Katrina论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAMartin, Michael论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USARen, Pingda论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USAFruman, David论文数: 0 引用数: 0 h-index: 0机构: UC Irvine, Irvine, CA USA Intellikine, La Jolla, CA USARommel, Christian论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USALiu, Yi论文数: 0 引用数: 0 h-index: 0机构: Intellikine, La Jolla, CA USA Intellikine, La Jolla, CA USA